Inga Galuba

Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor.

D. Fabbro, W. Jahnke, G. Rummel, 2015, ACS medicinal chemistry letters.

In silico labeling enables kinetic myelination assay in brightfield

Vincent Unterreiner, Xian Zhang, Oleksandr Dergai, 2022, bioRxiv.

Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4.

W. Jahnke, P. Couttet, N. Ostermann, 2020, Journal of medicinal chemistry.

Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge region.

P. Furet, C. Leblanc, Christine C Genick, 2017, MedChemComm.

2-Formylpyridyl Ureas as Highly Selective Reversible-Covalent Inhibitors of Fibroblast Growth Factor Receptor 4.

P. Furet, C. Leblanc, M. Wartmann, 2018, ACS medicinal chemistry letters.

Association of time to recurrence with thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression in stage II and III colorectal cancer

M. Kornmann, E. Kreuser, K. Ridwelski, 2002, Journal of Gastrointestinal Surgery.

Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge region.

P. Furet, C. Leblanc, Christine C Genick, 2017, MedChemComm.